Singular Genomics Systems Statistics

Total Valuation

OMIC has a market cap or net worth of $48.

Market Cap	48
Enterprise Value	n/a

Important Dates

The last earnings date was Monday, March 17, 2025, after market close.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.00
Forward PS	4.63
PB Ratio	0.00
P/TBV Ratio	n/a
P/FCF Ratio	0.00
P/OCF Ratio	0.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.06, with a Debt / Equity ratio of 0.41.

Current Ratio	0.06
Quick Ratio	0.05
Debt / Equity	0.41
Debt / EBITDA	1.90
Debt / FCF	6.31
Interest Coverage	0.95

Financial Efficiency

Return on equity (ROE) is -10.39% and return on invested capital (ROIC) is 2.18%.

Return on Equity (ROE)	-10.39%
Return on Assets (ROA)	0.90%
Return on Invested Capital (ROIC)	2.18%
Return on Capital Employed (ROCE)	4.59%
Revenue Per Employee	$215,773
Profits Per Employee	-$40,593
Employee Count	255
Asset Turnover	0.15
Inventory Turnover	0.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.09% in the last 52 weeks. The beta is 1.84, so OMIC's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	+26.09%
50-Day Moving Average	19.81
200-Day Moving Average	14.23
Relative Strength Index (RSI)	56.73
Average Volume (20 Days)	7,803

Short Selling Information

The latest short interest is 44,745, so 1.77% of the outstanding shares have been sold short.

Short Interest	44,745
Short Previous Month	45,429
Short % of Shares Out	1.77%
Short % of Float	2.41%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OMIC had revenue of $1.94 million and -$365,340 in losses. Loss per share was -$0.01.

Revenue	1.94M
Gross Profit	392,100
Operating Income	180,458
Pretax Income	-365,340
Net Income	-365,340
EBITDA	590,561
EBIT	180,458
Loss Per Share	-$0.01

Full Income Statement

Balance Sheet

The company has $113 in cash and $1.30 million in debt, giving a net cash position of -$1.30 million.

Cash & Cash Equivalents	113
Total Debt	1.30M
Net Cash	-1.30M
Net Cash Per Share	n/a
Equity (Book Value)	3.16M
Book Value Per Share	0.06
Working Capital	-2.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $212,259 and capital expenditures -$6,319, giving a free cash flow of $205,940.

Operating Cash Flow	212,259
Capital Expenditures	-6,319
Free Cash Flow	205,940
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 20.19%, with operating and profit margins of 9.29% and -18.81%.

Gross Margin	20.19%
Operating Margin	9.29%
Pretax Margin	-18.81%
Profit Margin	-18.81%
EBITDA Margin	30.41%
EBIT Margin	9.29%
FCF Margin	10.60%

Dividends & Yields

OMIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.51%
Shareholder Yield	n/a
Earnings Yield	-761,125.00%
FCF Yield	429,041.67%

Analyst Forecast

Price Target	n/a
Price Target Difference	-46.28%
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OMIC has an Altman Z-Score of -9.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.41
Piotroski F-Score	3